Tumour forming efficiencies of TUBO cell line expressing Her2 in two different mice strains with Matrigel matrix to develop animal models for novel immunotherapies

dc.contributor.authorAnil, M.
dc.contributor.authorIz, S. Gulce
dc.contributor.authorMetiner, P. Saglam
dc.contributor.authorSahar, E. Atalay
dc.contributor.authorCan, H.
dc.contributor.authorZekioglu, O.
dc.contributor.authorDoskaya, M.
dc.contributor.authorYeniay, L.
dc.date.accessioned2019-10-27T23:11:15Z
dc.date.available2019-10-27T23:11:15Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS12en_US
dc.identifier.issn0959-8049
dc.identifier.issn1879-0852
dc.identifier.startpageS12en_US
dc.identifier.urihttps://hdl.handle.net/11454/53045
dc.identifier.volume55en_US
dc.identifier.wosWOS:000431638500033en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal of Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTumour forming efficiencies of TUBO cell line expressing Her2 in two different mice strains with Matrigel matrix to develop animal models for novel immunotherapiesen_US
dc.typeConference Objecten_US

Dosyalar